Global vaccine action plan

1

The Global Vaccine Action Plan

Agenda item 5(c)62nd Session of the WHO Regional Committee for the Eastern

Mediterranean58 October 2015

The Global Vaccine Action Plan2

Outline• Global Vaccine Action Plan

– Goals– Regional progress– Challenges faced in the Region

• Draft Eastern Mediterranean Vaccine Action Plan 20162020 – Vision– Goals – Strategic objectives– Monitoring and evaluation framework– What is expected from the Member States


The Global Vaccine Action Plan

• Operational framework for implementation of the vision and mission of and achieving the goals of the Decade of Vaccines 20112020

• Endorsed by the World Health Assembly in May 2012 (resolution WHA65.17)


Goals of the Decade of Vaccines • Achieve a world free of polio• Meet vaccination coverage targets in every

region, country and community• Meet global and regional elimination targets• Develop and introduce new and improved

vaccines and technologies• Exceed the MDG 4 target for reduction of

child mortality


Regional progress towards achieving the goals of the

Decade


Palestine

Bahrain

Polio endemic countries

Poliomyelitis


WHOUNICEF estimates of DTP3 coverage, 2014

Afghan

istan

Bahrai

n

Djibou

ti

Egypt

Islam

ic Rep

ublic

of Ira

nIra

q

Jorda

n

Kuwait

Leba

nonLib

ya

Morocc

oOman

Pakist

an

Palesti

neQata

r

Saudi

Arabia

Somali

a

Sudan

Syrian

Arab

Rep

ublic

Tunisi

a

United

Arab

Emira

tes

Yemen

0

10

20

30

40

50

60

70

80

90

100

% c

over

age

Source: WHOUNICEF estimates

DTP3 unvac-cinated3.2 mil-

lion, 19%

DTP3 vacci-nated

14.2 mil-lion, 81%

DTP3 unvaccinatedDTP3 vaccinated

DTP3: 3.2 million unvaccinated infants in the Region, 2014

Source: WHOUNICEF estimates

Pakistan47%

Iraq14%

Afghanistan

10%

Syrian Arab

Republic10%

Somalia6%

Egypt4%

Yemen3%

Sudan3% others

3%

8The Global Vaccine Action Plan


Source: Countries’ reportsKuwait: no reports in 2014

EMR incidence rate: 14.79/million

Somalia

Leba

non

United

Ara

b Emira

tes

YemenIra

qLib

ya

Syrian A

rab R

epub

licQatar

Afghan

istan

Sudan

Egypt

Pakistan

Djibouti

Oman

Saudi A

rabia

Jord

an

Tunisi

a

Islamic

Republi

c of Ir

an

Morocc

o

Bahrain

Palestin

e0

20

40

60

80

100

120113.7

54.0

41.6

35.5 34.930.3

28.1 26.5

20.8 20.7 20.4

7.7 6.94.4 2.4 1.6 0.9 0.8 0.3 0.0 0.0

Incidence rate of confirmed measles cases, 2014

Inci

denc

e/m

illio

n po

pula

tion

< 1/

mill

ion

popu

latio

n

High endemicity/major outbreaks

15/

mill

ion

popu

latio

nSource: National reports


Palestine

Maternal and neonatal tetanus elimination

Bahrain

MNT not eliminatedMNT eliminated

New vaccine introductionCurrently offered to

65% of live births

Palestine

Bahrain

Pneumococcal vaccine introduction

Introduced (14)Not introduced (8)

Palestine

Bahrain

Rotavirus vaccine introduction

Introduced (11)

Not introduced (11)

Currently offered to

30% of live births

11


Challenges and constraints• The geopolitical situation in several countries• Inadequate managerial capacity coupled with the

multiple competing priorities in some countries• Inadequate attention to or visibility of the immunization

goals other than polio eradication• Inadequate allocation of domestic resources • Inadequate vaccine registration and procurement

systems• Inadequate social mobilization and demand creation• Weak surveillance systems for vaccine-preventable

diseases and poor immunization data quality in some countries


Eastern Mediterranean Vaccine Action Plan (EMVAP)

20162020


EMVAP 20162020• Developed in response to resolution

WHA65.17• A framework for implementation of the Global

Vaccine Action Plan• Renews commitments of Member States to

the global and regional immunization goals• Defines the objectives, priority actions and

indicators of immunization programmes, taking into account specific needs and challenges of countries of the Region


EMVAP 20162020 • Vision: a region in which all individuals

enjoy lives free of vaccine-preventable diseases

• Aims at ensuring equitable access, of all communities and individuals, especially those marginalized and in hard-to-reach areas, to sustainable access to vaccines of assured qualities


Goals1. Attain interruption and sustain polio-free status2. Meet regional routine vaccination coverage

targets at all administrative levels 3. Meet regional disease elimination and control

targets – Achieving measles elimination– Achieving and sustaining elimination of maternal and

neonatal tetanus– Achieving the regional hepatitis B reduction goal

4. Introduce new vaccines of regional and national priority


Strategic objectives1. All countries commit to immunization as a priority

2. Individuals and communities understand the value of vaccines and demand vaccination as their rights and responsibilities

3. The benefits of vaccination are extended equitably to all people through tailored, innovative strategies

4. Strong immunization systems are an integral part of a well-functioning health system

5. Immunization programmes have sustainable access to long term funding and high-quality supply


Priority actions

• EMVAP proposes a list of priority actions for each strategic objective

• Priority actions are tailored to address:– the current situation of immunization

programmes in the Region– specificities and challenges currently faced by

the Region


Monitoring and evaluation framework

• EMVAP 20162020 proposes a monitoring and evaluation framework with specific indicators for:– monitoring implementation of the priority actions

of the different strategic objectives– monitoring progress towards achieving the goals

of the plan– reporting to the Regional Committee annually on

the progress made and remaining challenges


What is expected from Member States• Renewing commitments to immunization programmes• Providing input to and endorsing EMVAP 20162020 • Using EMVAP as a framework for developing and

updating the comprehensive multiyear plans (cMYP) for immunization in order to achieve the regional immunization goals

• Allocating and mobilizing resources necessary for implementation of EMVAP 20162020


THANK YOU

Health & Medicine

Global vaccine action plan